PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Data Insights
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Awards & Rankings
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Powder Handling
Future Pharma Services
Putting quality first in the pharma supply chain
Accelerating Biopharmaceutical Innovation
Accelerating global access to medicines
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Data Insights
Projects
Latest
Price point is a key factor for wider market adoption of Amgen’s Amjevita in the US
HIV vaccines suffer setbacks but new approaches could turn the tide
Magazine: CRISPR gene therapies cut through in 2023
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Qurient partners with TB Alliance to develop telacebec
FDA grants approval to Gilead Sciences’ breast cancer therapy
US FDA approves Amgen-AstraZeneca’s Tezspire for asthma treatment
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Pfizer’s Synthesis Facility, Ringaskiddy, Ireland
China’s NMPA conditionally approves two oral drugs for Covid-19
Health Canada accepts Veru’s Covid-19 therapy NDS-CV for review
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Merck reports 2% increase in worldwide sales in Q4 2022
Pfizer reports 30% operational growth in full-year 2022 revenues
Who’s hiring who? Hiring activity related to robotics increased by 11% in the pharmaceutical industry in Q3 2022
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Modernizing cell culture processes for the next wave of genomic medicine
Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing
How gas filter classification standards help users make the right selection
Events
Reports
PT
Companies involved
B Medical Systems
Veeprho Pharmaceutical
LB Bohle
Fortis Life Sciences
Learnship Networks
LAST Technology
Sofgen Pharmaceuticals, part of Procaps Group
Insilico Medicine
Multiply Labs
Danaher (Cytiva)
Charles River Laboratories
ABB
Getinge
Zipline International
Thermo Fisher Scientific
Most Popular
Pliant snags $287.5 million in oversubscribed public offering amid market uncertainty
Feinstein Institutes researchers discover new protein for sepsis treatment
Qurient partners with TB Alliance to develop telacebec
FDA grants approval to Gilead Sciences’ breast cancer therapy
Price point is a key factor for wider market adoption of Amgen’s Amjevita in the US
